 BOSTON and HOUSTON, Sept. 01, 2021 GLOBE NEWSWIRE -- Ziopharm Oncology, Inc. Ziopharm or the Company Nasdaq: ZIOP, today announced that Kevin S. Boyle, Sr., Chief Executive Officer of Ziopharm, is scheduled to participate in five upcoming virtual investor conferences: 